Several risk factors are able to predict non-alcoholic fatty liver (NAFL) development, but the predictive value of serum alkaline phosphatase (ALP) remains uncertain. Our aim is to investigate the association between serum ALP levels and NAFL. 21,331 NAFL-free subjects were included. Sex-...
Alkaline Phosphatase may be increased up to twice normal Serum Bilirubin may be increased enough to cause visible Jaundice HELLP Syndrome May be most difficult to distinguish from Acute Fatty Liver of Pregnancy Often associated with Preeclampsia with Severe Hypertension and Proteinuria Most commonly occu...
Fatty liver disease is a growing problem in fish aquaculture and there is an urgent need to identify causes and possible remedies. In the present study, the effects of treating fatty liver disease in the Nile tilapia (Oreochromis niloticus Linnaeus, 1758) with an extract derived from a herb, ...
Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer-related deaths among women worldwide [1]. Its initiation and progression are complex and influenced by various factors that are still under investigation. Non-alcoholic fatty liver disease (NAFLD), the most prevalen...
The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). At present, the COVID-19 has been prevalent worldwide for more than a year and caused more than four million deaths. Liver injury
We showed that genetic variants within the MTARC1 locus are associated with liver enzymes, liver fat, plasma lipids, and body composition, and these associations are attributable to the same causal variant (p.A165T, rs2642438 G>A), suggesting a shared mechanism. We demonstrated that increased ...
After 6 months, the intervention group showed significantly lower risks for ALT (RR: 0.72, 95% CI: 0.62鈥 0.84), AST, and alkaline phosphatase (Alkp) abnormalities. Liver enzyme levels (ALT, AST, GGT) and systolic blood pressure (SBP) decreased significantly in the Empagliflozin group, with...
Non-alcoholic Fatty Liver Disease (NAFLD) shown frequent future in patients with type 2 Diabetes Mellitus (DM2). By affecting insulin metabolism, glucose production and gluconeogenesis liver disorders probably involved into DM2 clinical future and development of complications. We studied the role of ...
We also collected data on liver and renal function tests including alanine aminotransferase (ALT), alkaline phosphatase (ALP), glutamyltransferase (GGT), total protein (TP), albumin (ALB), urea, uric acid, creatinine was also measured. Diagnosis of MS and NAFLD The study endpoint was the ...
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64(5):1577-1586. doi:10.1002/hep.28785PubMedGoogle ScholarCrossref 5. Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk...